Potential drug–drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan
Abstract Background Potential drug–drug interactions (PDDIs) commonly occur because of aging and comorbidities in people living with human immunodeficiency virus (HIV; PLWH). Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have been reported to cause PDDIs in these patients....
Guardado en:
Autores principales: | Yusuke Kunimoto, Ryosuke Matamura, Hiroshi Ikeda, Satoshi Fujii, Tomoko Kimyo, Manabu Kitagawa, Hiromasa Nakata, Masayoshi Kobune, Atsushi Miyamoto, Masahide Fukudo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/36b085886ff641c9923eba261607d847 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of the long-terminal repeat single-strand tail-binding site of Moloney-MuLV integrase by crosslinking
por: VERA,JORGE, et al.
Publicado: (2008) -
How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir
por: Atze T. Das, et al.
Publicado: (2018) -
Interactions between prescription drugs in hospitalized geriatric patients
por: Erika Palacios-Rosas, et al.
Publicado: (2021) -
Reversal of Epigenetic Silencing Allows Robust HIV-1 Replication in the Absence of Integrase Function
por: Ishak D. Irwan, et al.
Publicado: (2020) -
Interacciones de medicamentos y eventos adversos en fármacos utilizados en una unidad de cuidados intensivos
por: PLAZA,JULIO, et al.
Publicado: (2010)